ranolazine

FDA Drug Profile

Drug Details

Generic Name
ranolazine
Brand Names
N/A
Application Number
Sponsor
Jubilant Biosys limited
NDC Codes
1
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
RANOLAZINE

Indications and Usage

1 INDICATIONS AND USAGE Ranolazine extended-release tablet is indicated for the treatment of chronic angina. Ranolazine extended-release tablet may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, and angiotensin receptor blockers. Ranolazine extended-release tablet is an antianginal indicated for the treatment of chronic angina. ( 1 )